HEPATIC TOXICITY OF LIPOSOMAL ENCAPSULATED DOXORUBICIN

被引：5
作者：
COKER, RJ
JAMES, ND
STEWART, JSW
机构：
[1] ST MARYS HOSP,DEPT COMMUNICABLE DIS,LONDON W2 1NY,ENGLAND
[2] ST MARYS HOSP,DEPT ONCOL,LONDON W2 1NY,ENGLAND
来源：
LANCET | 1993年 / 341卷 / 8847期
关键词：
D O I：
10.1016/0140-6736(93)90525-L
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 4 条
[1]  
GREGORIADES G, 1988, LIPOSOMES DRUG CARRI
[2]  
HENGGE, 1993, LANCET, V341, P383
[3]   KAPOSIS SARCOMA IN THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME - A PROPOSAL FOR UNIFORM EVALUATION, RESPONSE, AND STAGING CRITERIA [J].
KROWN, SE ;
METROKA, C ;
WERNZ, JC .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1201-1207
[4]   STERICALLY STABILIZED LIPOSOMES - IMPROVEMENTS IN PHARMACOKINETICS AND ANTITUMOR THERAPEUTIC EFFICACY [J].
PAPAHADJOPOULOS, D ;
ALLEN, TM ;
GABIZON, A ;
MAYHEW, E ;
MATTHAY, K ;
HUANG, SK ;
LEE, KD ;
WOODLE, MC ;
LASIC, DD ;
REDEMANN, C ;
MARTIN, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11460-11464
1